Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma

被引：5
|
作者：
Ahn, Hee Kyung [1 ]
Lee, Soohyeon [1 ]
Sun, Jong-Mu [1 ]
Lee, Jeeyun [1 ]
Park, Se Hoon [1 ]
Park, Joon Oh [1 ]
Park, Young Suk [1 ]
Kang, Won Ki [1 ]
Lim, Ho Yeong [1 ]
机构：
[1] Sungkyunkwan Univ, Samsung Med Ctr, Div Hematol Oncol, Dept Med,Sch Med, Seoul 135710, South Korea
来源：
INVESTIGATIONAL NEW DRUGS | 2012年 / 30卷 / 04期
关键词：
RENAL-CELL CARCINOMA; EFFICACY; PROGRESSION;
D O I：
10.1007/s10637-011-9707-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1768 / 1772
页数：5
相关论文
共 50 条
  • [41] Sequential targeted therapy (TT) with sorafenib-sunitinib (SO-SU) versus sunitinib-sorafenib (SU-SO) in metastatic renal cell carcinoma (mRCC): Results from a case-series of patients
    Biondani, P.
    Torri, V.
    Verzoni, E.
    Porcu, L.
    Grassi, R.
    Testa, I.
    Pusceddu, S.
    Garanzini, E.
    De Braud, F.
    Procopio, G.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S650 - S650
  • [42] Target Therapy for Hepatocellular Carcinoma: Is Sorafenib for Everybody?
    Daniele, Bruno
    Di Maio, Massimo
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (05) : 389 - 390
  • [43] Systemic therapy for hepatocellular carcinoma: beyond sorafenib
    Boland, Patrick
    Wu, Jennifer
    [J]. CHINESE CLINICAL ONCOLOGY, 2018, 7 (05)
  • [44] Sunitinib versus sorafenib plus transarterial chemoembolization for inoperable hepatocellular carcinoma patients
    Xu, Qiang
    Huang, Youhua
    Shi, Hongjian
    Song, Qian
    Xu, Yuanfeng
    [J]. JOURNAL OF BUON, 2018, 23 (01): : 193 - 199
  • [45] Sunitinib in Patients with Advanced Hepatocellular Carcinoma after Progression under Sorafenib Treatment
    Woerns, Marcus Alexander
    Schuchmann, Marcus
    Dueber, Christoph
    Otto, Gerd
    Galle, Peter Robert
    Weinmann, Arndt
    [J]. ONCOLOGY, 2010, 79 (1-2) : 85 - 92
  • [46] Sorafenib and Triptolide as Combination Therapy for Hepatocellular Carcinoma
    Alsaied, Osama
    Sangwan, Veena
    Banerjee, Sulagna
    Chugh, Rohit
    Saluja, Ashok
    Vickers, Selwyn M.
    Jensen, Eric
    [J]. HEPATOLOGY, 2013, 58 : 1073A - 1073A
  • [47] Sorafenib and triptolide as combination therapy for hepatocellular carcinoma
    Alsaied, Osama A.
    Sangwan, Veena
    Banerjee, Sulagna
    Krosch, Tara C.
    Chugh, Rohit
    Saluja, Ashok
    Vickers, Selwyn M.
    Jensen, Eric H.
    [J]. SURGERY, 2014, 156 (02) : 270 - 279
  • [48] Multicenter Phase II Study of Sequential Radioembolization-Sorafenib Therapy for Inoperable Hepatocellular Carcinoma
    Chow, Pierce K. H.
    Poon, Donald Y. H.
    Khin, Maung-Win
    Singh, Harjit
    Han, Ho-Seong
    Goh, Anthony S. W.
    Choo, Su-Pin
    Lai, Hee-Kit
    Lo, Richard H. G.
    Tay, Kiang-Hiong
    Lim, Teong-Guan
    Gandhi, Mihir
    Tan, Say-Beng
    Soo, Khee-Chee
    [J]. PLOS ONE, 2014, 9 (03):
  • [49] Sorafenib-Regorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma: A Single-Institute Experience
    Ueshima, Kazuomi
    Nishida, Naoshi
    Kudo, Masatoshi
    [J]. DIGESTIVE DISEASES, 2017, 35 (06) : 611 - 617
  • [50] SAFETY PROFILE OF SUNITINIB AND SORAFENIB IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)
    Massari, Francesco
    Sperandi, Francesca
    Cricca, Antonia
    Melotti, Barbara
    Martoni, Andrea Angelo
    [J]. ANNALS OF ONCOLOGY, 2009, 20
12345